Present and future role of FDG-PET/CT imaging in the management of head and neck carcinoma

被引：0
作者：
Kazuhiro Kitajima
Yuko Suenaga
Kazuro Sugimura
机构：
[1] Hyogo College of Medicine,Department of Nuclear Medicine and PET Center
[2] Kobe University Graduate School of Medicine,Department of Radiology
来源：
Japanese Journal of Radiology | 2015年 / 33卷
关键词：
Fluorodeoxyglucose (FDG); Positron emission tomography/computed tomography (PET/CT); Head and neck carcinoma; Staging; Restaging;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Integrated positron emission tomography/computed tomography (PET/CT) with 2-[18F]fluoro-2-deoxy-d-glucose (FDG) is a useful technique for acquisition of both glucose metabolic and anatomic imaging data using a single device in a single diagnostic session, and has opened a new field in clinical oncologic imaging. FDG-PET/CT has been used successfully for the initial staging, restaging, monitoring of the response to therapy, and prognostication of head and neck carcinoma. The present review discusses the current role of FDG-PET/CT in the management of head and neck carcinoma, focusing on its usefulness and limitations for imaging in these patients.
引用
收藏
页码：776 / 789
页数：13
相关论文
共 565 条
[1]  
Fleming AJ(2007)Impact of [ Laryngoscope 117 1173-1179
[2]  
Smith SP(2007)F]-2-fluorodeoxyglucose-positron emission tomography/computed tomography on previously untreated head and neck cancer patients Otolaryngol Head Neck Surg 137 130-137
[3]  
Paul CM(2007)The role of FDG-PET/CT imaging in head and neck malignant conditions: impact on diagnostic accuracy and patient care Head Neck 29 986-995
[4]  
Hall NC(2007)Clinical impact of, and prognostic stratification by, F-18 FDG PET/CT in head and neck mucosal squamous cell carcinoma Eur J Nucl Med Mol Imaging 34 1953-1962
[5]  
Daly BT(2007)TNM staging with FDG-PET/CT in patients with primary head and neck cancer Ann Oncol 18 1698-1703
[6]  
Agrawal A(2009)Combined Eur J Nucl Med Mol Imaging 36 919-927
[7]  
Gordin A(2013)F-fluorodeoxyglucose-positron emission tomography and computed tomography as a primary screening method for detecting second primary cancers and distant metastases in patients with head and neck cancer Clin Oncol ( Coll Radiol 25 e33-e66
[8]  
Golz A(2010)Head and neck squamous cell carcinoma (HNSCC)—detection of synchronous primaries with J Clin Oncol 28 1190-1195
[9]  
Keidar Z(2008)F-FDG-PET/CT Radiology 249 551-559
[10]  
Daitzchman M(2008)Evidence-based guideline recommendations on the use of positron emission tomography imaging in head and neck cancer Eur J Radiol 66 460-479
12345678910